SANTA BARBARA, Calif.--(BUSINESS WIRE)--April 21, 2006--Mentor Corporation (NYSE:MNT - News), a leading supplier of medical products in the United States and internationally, today announced that it has received U.S. Food and Drug Administration approval to begin marketing its new NovaSilk(TM) synthetic mesh product used in the treatment of pelvic organ prolapse in the United States.
